跳至主要内容
临床试验/IRCT2014111119912N1
IRCT2014111119912N1已完成未知

Evaluation the effect of squill oxymel, Traditional Medicine product, in the treatment of moderate to severe asthma in patients 18 to 70 years old: triple-blind randomized Clinical trial

College of Traditional Medicine of Tehran University of Medical Sciences0 个研究点目标入组 51 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Age 18 to 70 years; asthma patients with moderate to severe asthma who have clinical criteria include: FEV1 between 40% to 80% of the predicted and asthma that was insufficiently controlled despite treatment with medium or high dose inhaled corticosteroids; treated with conventional drugs; Lack of pregnancy; Lack of breastfeeding; Lack of the use other herbal medicines; Lack of active peptic ulcer and cardiovascular disease (especially heart block) or renal disease; Not concomitant use of anticoagulant; Non-smoking.
  • Exclusion criteria: Add or remove the drugs that interferes with asthma (such as NSAIDs); Infections leading to hospitalization; the patient's unwillingness to continue treatment.

排除标准

  • 未提供

研究者

发起方
College of Traditional Medicine of Tehran University of Medical Sciences

相似试验